[Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors]

Gang Xie1, Jing Cheng1, Junping Zhang1

  • 1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.

Insights

Chemokine-like factor-like MARVEL transmembrane domain containing member (CMTM) proteins are implicated in cancer development, growth, and immune evasion. CMTM4/CMTM6 regulate PD-L1, highlighting their potential as cancer drug targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Chemokine-like factor-like MARVEL transmembrane domain containing member (CMTM/CKLFSF) proteins link chemokines and transmembrane superfamilies.
  • CMTMs exhibit broad chemotactic activities and are closely associated with the hematopoietic and immune systems, as well as tumor development and metastasis.

Approach:

  • This review synthesizes current research on the role of CMTM family members in cancer.
  • It specifically examines their involvement in tumor growth, metastasis, and immune escape.
  • The paper highlights recent findings concerning CMTM and non-small cell lung cancer.

Key Points:

  • CMTM proteins are integral to key cancer development processes, including growth factor receptor regulation, cell proliferation, metastasis, and tumor immune microenvironment modulation.
  • CMTM4 and CMTM6 are identified as regulators of programmed cell death ligand 1 (PD-L1), a critical factor in tumor immune evasion.
  • The study emphasizes the emerging understanding of CMTM's role in cancer biology.

Conclusions:

  • CMTM family members play a significant role in various aspects of cancer progression and immune response.
  • CMTMs represent a promising area for novel cancer therapeutic strategies and biomarker development.
  • Further research into CMTM's clinical value, particularly in non-small cell lung cancer, is warranted.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K